These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5789862)

  • 1. Hypothermia with epodyl in the treatment of cancer of the head and neck.
    Harrison DF
    Geriatrics; 1969 Jul; 24(7):87-97. PubMed ID: 5789862
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypothermia: an aid to cancer chemotherapy.
    Harrison DF
    Nurs Times; 1967 Nov; 63(46):1536-8. PubMed ID: 6054792
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy in malignant neoplasms of the head and neck.
    Eye Ear Nose Throat Mon; 1969 Sep; 48(9):497-8. PubMed ID: 5802545
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy in head and neck malignancies.
    Mendelsohn M
    Eye Ear Nose Throat Mon; 1969 Sep; 48(9):501-5. PubMed ID: 5802546
    [No Abstract]   [Full Text] [Related]  

  • 5. [Systemic administration of antineoplastic agents in head and neck cancer].
    Kawabe Y
    Nihon Jibiinkoka Gakkai Kaiho; 1972 Dec; 75(12):1467. PubMed ID: 4675772
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions between ionizing radiation and drugs in head and neck cancer: how can we maximize the therapeutic index?
    Harrington KJ; Nutting CM
    Curr Opin Investig Drugs; 2002 May; 3(5):807-11. PubMed ID: 12090557
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined modality therapy of head and neck cancer.
    Stupp R; Weichselbaum RR; Vokes EE
    Semin Oncol; 1994 Jun; 21(3):349-58. PubMed ID: 8209266
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant tumor chemotherapy in advanced head and neck cancer.
    O'Keefe JJ; Weiss
    Trans Am Laryngol Rhinol Otol Soc; 1965; ():69-81. PubMed ID: 5861965
    [No Abstract]   [Full Text] [Related]  

  • 9. [A device for fractional drip infusion of drugs in the treatment of malignant tumors of the head and neck].
    Shikov VG; Gamburg IuL; Nechaev IuB
    Stomatologiia (Mosk); 1967; 46(6):91-2. PubMed ID: 5235971
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences with chemotherapy for progressive cancer of the head and neck metastasizing to the remote parts].
    Kawabe Y; Yokoi H; Kondo T
    Jibiinkoka; 1966 Nov; 38(11):1199-203. PubMed ID: 6009820
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolving strategies for combined-modality therapy for locally advanced head and neck cancer.
    Posner M
    Oncologist; 2007 Aug; 12(8):967-74. PubMed ID: 17766656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy scores against cancer.
    Anderson WF
    Nat Med; 2000 Aug; 6(8):862-3. PubMed ID: 10932216
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
    Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Other new drugs in head and neck cancer.
    de Jonge MJ
    Acta Otorhinolaryngol Belg; 1999; 53(3):259-61. PubMed ID: 10635405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Potentiation of the therapeutic activity of antiblastic drugs by means of regional hyperoxygenation].
    Nervi C; Casale C; Cortese M
    Policlinico Med; 1969; 76(6):335-42. PubMed ID: 5396255
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of chemotherapy to cure head and neck cancer.
    Taylor SG
    J Infus Chemother; 1995; 5(2):44-5. PubMed ID: 8521233
    [No Abstract]   [Full Text] [Related]  

  • 17. Progress and perspectives in chemoprevention of head and neck cancer.
    Wirth LJ; Haddad RI; Posner MR
    Expert Rev Anticancer Ther; 2003 Jun; 3(3):339-55. PubMed ID: 12820777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of head and neck cancer.
    Guthrie TH
    J Med Assoc Ga; 1981 Jan; 70(1):57-9. PubMed ID: 7217796
    [No Abstract]   [Full Text] [Related]  

  • 19. VB4-845, a conjugated recombinant antibody and immunotoxin for head and neck cancer and bladder cancer.
    Biggers K; Scheinfeld N
    Curr Opin Mol Ther; 2008 Apr; 10(2):176-86. PubMed ID: 18386230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation and chemotherapy as combined treatment for advanced head and neck cancer.
    Witt ME
    Medsurg Nurs; 1998 Jun; 7(3):159-64. PubMed ID: 9727134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.